AIMProteus
             AKT Inhibitor Miransertib on Proteus Syndrome  - Targeted therapy at NIH

Update:  The AIM Proteus Trial is currently is currently on hold.

Approximate patient enrollment date for trial Summer 2021. 


Questions about the NIH AIMProteus trial email here or call.